New York State Common Retirement Fund Compass Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $75.2 Billion
- Q2 2025
A detailed history of New York State Common Retirement Fund transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 30,407 shares of CMPX stock, worth $112,809. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,407
Previous 30,407
-0.0%
Holding current value
$112,809
Previous $58,000
36.21%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CMPX
# of Institutions
106Shares Held
101MCall Options Held
18.2KPut Options Held
2.51M-
Orbimed Advisors LLC San Diego, CA15.2MShares$56.5 Million1.41% of portfolio
-
Tang Capital Management LLC San Diego, CA13.5MShares$50.1 Million2.1% of portfolio
-
Blackstone Inc New York, NY10MShares$37.2 Million0.12% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.15MShares$26.5 Million0.64% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$24.5 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $376M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...